SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Abeona Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-13 5:03 pm Purchase |
2024-05-03 | 13G | Abeona Therapeutics Inc. ABEO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,685,503 9.300% |
3,685,503 (New Position) |
Filing |